Inherited clotting disorders, such as Factor V Leiden mutation and Prothrombin gene mutation, can significantly elevate the risk of thromboembolic events in women. These conditions may necessitate personalized management strategies, particularly during high-risk periods like pregnancy, postpartum, and while using hormonal therapies.
